Helix BioPharma Corp. Opens the Market

TORONTO, May 26, 2016 /CNW/ - Dr. Sven Rohmann, CEO and President, Helix BioPharma Corp. (HBP), joined Richard Rohan, VP, Corporate Sales, TMX Equity Transfer & Trust Company, to open the market to celebrate 20 years listed on Toronto Stock Exchange. Helix BioPharma Corp. is a biopharmaceutical company specializing in the development and commercialization of medicines in the areas of cancer prevention and treatment. Helix BioPharma Corp. commenced trading on Toronto Stock Exchange on June 3, 1996.

SOURCE TMX Group Limited

Image with caption: "Dr. Sven Rohmann, CEO and President, Helix BioPharma Corp. (HBP), joined Richard Rohan, VP, Corporate Sales, TMX Equity Transfer & Trust Company, to open the market to celebrate 20 years listed on Toronto Stock Exchange. Helix BioPharma Corp. is a biopharmaceutical company specializing in the development and commercialization of medicines in the areas of cancer prevention and treatment. Helix BioPharma Corp. commenced trading on Toronto Stock Exchange on June 3, 1996. (CNW Group/TMX Group Limited)". Image available at: http://photos.newswire.ca/images/download/20160526_C2748_PHOTO_EN_700484.jpg


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890